Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis

NCT00035178 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure, Chronic
Renal Disease, End-Stage

Interventions

DRUG: Argatroban

Sponsor

Texas Biotechnology Corporation